REGEN BIOPHARMA, INC. (RGBPP) Revenue 2017–2025
REGEN BIOPHARMA, INC. (RGBPP) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$236,561FY2025 · since FY2017: $110,000 → $236,561
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $236,561 | +0.0% |
| FY2024 | $236,560 | +0.0% |
| FY2023 | $236,560 | +88.5% |
| FY2022 | $125,517 | +105.1% |
| FY2021 | $61,194 | -44.4% |
| FY2020 | $110,000 | +0.0% |
| FY2019 | $110,000 | +10.0% |
| FY2018 | $100,000 | -9.1% |
| FY2017 | $110,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RGBPP financial trends
RGBPP Net incomeRGBPP Net marginRGBPP Gross profitRGBPP Gross marginRGBPP Operating incomeRGBPP Operating marginRGBPP Operating cash flowRGBPP Free cash flowRGBPP Capital expendituresRGBPP Return on equityRGBPP Stock buybacksRGBPP Dividends paidRGBPP Total assetsRGBPP Total liabilitiesRGBPP Shareholders’ equityRGBPP overview →